Pediatric Neuro-Oncologist and Medical D

This is an incredible opportunity to join a collegial academic environment and work in childrens hospital with a childhood cancer program that U.S. News ranks among the top 20 in the nation. The Division of Pediatric Hematology Oncology in the Department of Pediatrics and the Division of Pediatric Neurosurgery, University of Utah School of Medicine are jointly recruiting a Pediatric Neuro-Oncologist physician who will also serve as the Medical Director for the Pediatric Neuro-Oncology Program. The Director will lead a multidisciplinary team of pediatric neuro-oncology professionals who will manage care of pediatric neuro-oncology patients at Primary Childrens Hospital (PCH) in the Pediatric Hematology-Oncology Service Line outpatient and inpatient units. The Pediatric Neuro-Oncology team will work closely with colleagues and investigators in Pediatric Hematology-Oncology, Pediatric BMT, Pediatric and Adult Neurosurgery, Pediatric Neurology, Radiation Oncology, the Huntsman Cancer Institute (HCI) and the Department of Pediatrics. Pediatric Neurosurgery and Pediatric Neuro-Oncology see approximately 100 newly diagnosed pediatric brain tumor patients annually. The Director will oversee and provide leadership in the clinical, basic and translational research programs and will have the opportunity to implement early phase and investigator initiated clinical trials, as well as collaborations with the immunotherapy and cell therapy programs. The Director will also provide clinical patient care services. Opportunities to collaborate and/or lead clinical, translational and basic laboratory research projects/programs are available in the Department of Pediatrics and the HCI, which is a NCI designated comprehensive cancer center connected to PCH. There are ongoing projects in value-based care, supportive oncology/palliative care, clinical trials, cancer genetics, laboratory research, outcomes, late effects and AYA programs. Qualified candidates must be Board Qualified/Board Certified in Pediatrics and in Pediatric Hematology-Oncology with focused training in pediatric oncology, including neuro-oncology. Qualified candidates should also have a clinical and research (laboratory, translational, or clinical) focus in pediatric neuro-oncology. The selected candidate will receive a faculty appointment in the Department of Pediatrics on the Clinical or Tenure Track at the academic level commensurate with experience and qualifications. Interested individuals can apply at http://utah.peopleadmin.com/postings/101760. Cover letter and curriculum vitae are required. For additional information about the position, please contact: Richard S. Lemons, M.D., Ph.D., at richard.lemons@imail2.org. Cover letter and curriculum vitae are required. For additional information about the position, please contact: Richard S. Lemons, M.D., Ph.D., at richard.lemons@imail2.org. More information about the position: The Division of Pediatric Hematology Oncology is made up of 17 pediatric oncologists, including three pediatric BMT attendings, and two PhD investigators who focus in one of five areas: Oncology, Hematology, Bone Marrow Transplantation, Population Sciences and Cancer Control, or Pediatric Cancer Genetics. The Division houses the only pediatric BMT service in the Intermountain West, performs over 50 transplants annually, and has an active CAR T cell program. The Oncology section is made up of 12 physicians and the inpatient unit has 33 private patient rooms where all Hem/Onc patients are admitted. Inpatients are overseen by three Hem/Onc services an inpatient attending/resident/fellow H/O service, a chemotherapy attending/advanced practitioner service, and a BMT service with advanced practitioner support. All medical, pathology, radiologic and surgical subspecialties are represented in the childrens hospital. Primary Childrens Hospital is ranked by US News in the top 20 childhood cancer programs and provides care to children wi th cancer across the 5 state I termountain West region. The Department of Pediatrics ranks within the top 15 Pediatric Departments in NIH funding and has a premier research enterprise providing infrastructure, faculty mentoring and grant writing support. The University of Utah has a robust biotechnology and venture commercialization program. HCI is the only NCI-designated Comprehensive Cancer Center in the Mountain West and is a member of the National Comprehensive Cancer Network (NCCN), supporting and fostering a vibrant cancer research enterprise in a highly collegial environment. HCI has an outstanding history of academic achievement and impact, a collaborative environment, and a commitment to excellence in patient care, research, teaching, and service. Our integrated health system and HCIs participation in the ORIEN network of leading cancer centers provide outstanding opportunities for multidisciplinary collaborations in basic and translational laboratory-based cancer research, epidemiology and cancer biostatistics, as well as population-based studies of childhood cancers and outcomes. HCI has exceptional physical resources and recently completed a major expansion that includes a new 220,000 sq. ft. research building. In addition, the University of Utah and HCI are home to superb shared resources, such as the Utah Population Database with more than 16 million records linking genealogies, health records, and vital statistics. HCI and U of U Health provide access to state-of-the-art equipment and services through exceptional core facilities (see www.cores.utah.edu), including genomics/metabolomics/proteomics, a GMP-certified cell therapy and regenerative medicine facility, and a comprehensive biospecimen repository, which serve to enhance both discovery and translational science. The University of Utah Health (U of U Health) is a patient focused center distinguished by collaboration, excellence, leadership, and respect. The U of U Health values candidates who are committed to fostering and furthering the culture of compassion, collaboration, innovation, accountability, diversity, integrity, quality, and trust that is integral to our mission.